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Regulatory Dendritic Cells Restrain NK Cell IFN-g
Production through Mechanisms Involving NKp46, IL-10,
and MHC Class I–Specific Inhibitory Receptors
Rau´l G. Spallanzani,*,1 Nicola´s I. Torres,*,1 Damia´n E. Avila,*,†,1 Andrea Ziblat,*
Ximena L. Raffo Iraolagoitia,* Lucas E. Rossi,* Carolina I. Domaica,*
Mercedes B. Fuertes,*,‡ Gabriel A. Rabinovich,‡,x and Norberto W. Zwirner*,{
Cross-talk betweenmature dendritic cells (mDC) and NK cells through the cell surface receptors NKp30 and DNAM-1 leads to their
reciprocal activation. However, the impact of regulatory dendritic cells (regDC) on NK cell function remains unknown. As regDC
constrain the immune response in different physiological and pathological conditions, the aim of this work was to investigate the
functional outcome of the interaction between regDC and NK cells and the associated underlying mechanisms. RegDC generated
from monocyte-derived DC treated either with LPS and dexamethasone, vitamin D3, or vitamin D3 and dexamethasone instructed
NK cells to secrete lower amounts of IFN-g than NK cells exposed to mDC. Although regDC triggered upregulation of the
activation markers CD69 and CD25 on NK cells, they did not induce upregulation of CD56 as mDC, and silenced IFN-g secretion
through mechanisms involving insufficient secretion of IL-18, but not IL-12 or IL-15 and/or induction of NK cell apoptosis.
Blocking experiments demonstrated that regDC curb IFN-g secretion by NK cells through a dominant suppressive mechanism
involving IL-10, NK cell inhibitory receptors, and, unexpectedly, engagement of the activating receptor NKp46. Our findings
unveil a previously unrecognized cross-talk through which regDC shape NK cell function toward an alternative activated phe-
notype unable to secrete IFN-g, highlighting the plasticity of NK cells in response to tolerogenic stimuli. In addition, our findings
contribute to identify a novel inhibitory role for NKp46 in the control of NK cell function, and have broad implications in the
resolution of inflammatory responses and evasion of antitumor responses. The Journal of Immunology, 2015, 195: 2141–2148.
N
atural killer cells are key players during innate responses
against virus-infected cells and tumors, displaying cy-
totoxic activity and producing substantial amounts of
IFN-g and other proinflammatory cytokines during the develop-
ment of immune responses against such insults. In addition, NK
cells shape the adaptive immune response by interacting with
dendritic cells (DC), promoting DC maturation, Th1 polarization,
and CTL responses (1, 2). Such cross-talk between DC and NK
cells requires engagement of NKp30 and DNAM-1 and secretion
of cytokines, including IL-12, IL-15, IL-18, and IFN-g (3–7). In
addition, NK cells display effector functions upon recognition of
target cells through activating receptors such as CD16 (which
mediates Ab recognition of target cells); NKG2D; the natural
cytotoxicity receptors NKp46, NKp44, and NKp30; DNAM-1;
2B4; members of the killer Ig-like receptor (KIR) family that
carry a short cytoplasmic tail (KIR2DS and KIR3DS); and others
(8–10).
Myeloid DC exhibit a high degree of plasticity, as they can
differentiate into fully mature DC (mDC) or become regulatory DC
(regDC) under some circumstances (11–13), a functional charac-
teristic that is accompanied by the expression of particular co-
stimulatory molecules (14, 15). mDC have been shown to stimulate
IFN-g secretion by NK cells in a NKp30- and DNAM-1–dependent
manner (3, 4), resulting in a reciprocal activation of both cells. Such
cross-talk amplifies the adaptive immune response as NK cells en-
dow DC with the ability to promote Th1- and CTL-mediated effector
functions (1–3, 16). In addition, regDC are relevant for tumor pro-
gression (17–19) and for the resolution of immune responses (20).
Several approaches to generate regDC have been developed to har-
ness the immune response in different pathologic conditions such as
autoimmune diseases (21) and in allogeneic organ transplantation
(22), highlighting their potential therapeutic value. Known effects of
regDC include the induction of T cell anergy due to delivery of
defective costimulation to CD4+ and CD8+ T cells and expansion of
regulatory T cells (23). regDC can be generated by a variety of
immunoregulatory molecules, including IL-10 (24, 25), TGF-b (26),
vasoactive intestinal peptide (27), dexamethasone (DEX) (28, 29),
vitamin D3 (VitD3) (28), and galectin-1, a glycan-binding protein
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that triggers IL-27 production and promotes the generation of
IL-10–secreting Tr1 cells (20, 30–32). Moreover, the heterogeneity
of regDC-inducing agents reflects the fact that regDC might not
represent a specialized DC subset, but instead might encompass
a functional state of DC differentiation influenced by particular
environmental factors (13–15).
Although the impact of regDC on the T cell compartment has
been well established, their possible effects on NK cell physiology
remain unknown. In this study, we present evidence that indicates
that regDC restrain IFN-g secretion by NK cells through mecha-
nisms involving insufficient production of IL-18, secretion of IL-
10, engagement of MHC class I–specific inhibitory receptors, and,
unexpectedly, the activating receptor NKp46. Our results contribute
to unravel the mechanisms that regulate the interactions between
human regDC and NK cells at the crossroad of innate and adaptive
immunity and unveil a previously unanticipated function for NKp46
in the regulation of NK cell activation.
Materials and Methods
Abs and reagents
Human rIL-12 and rIL-15 were from PeproTech; human rIL-18 was fromMBL
International; human rGM-CSF and LPS (Escherichia coli 0111:B4 strain)
were from Sigma-Aldrich; and human rIL-4 was from BD Pharmingen. The
following mAb against human molecules were used: unlabeled anti-NKG2D
(clone 1D11; eBioscience); PE anti-NKp46 (9E2; BioLegend, San Diego,
CA); PE anti-NKG2A (R&D Systems), AlexaFluor488 anti-NKG2C (R&D
Systems); FITC anti-CD69 (FN50; BD); PE anti-CD25 (BC96; eBioscience);
PE anti–T-bet (4B10; eBioscience); PE anti-Helios (22F6; BioLegend); PE
anti–IL-18Ra (H44; BioLegend); PE anti–IL-18Rb (R&D Systems);
anti-NKp30 (clone AZ20); anti-NKp46 (clone BAB281) (provided by A.
Moretta, Laboratory of Molecular Immunology, Department of Experi-
mental Medicine, University of Genoa, Genoa, Italy); fluorochrome-labeled and
unlabeled isotype-matched control mAb (IC; eBioscience or BioLegend); PE
anti-CD3 (clone UCHT-1; eBioscience); PE/Cy5 anti-CD56 (clone N901;
Beckman Coulter); FITC anti-CD14 (clone HCD14; BioLegend); FITC anti–
HLA-DR (clone L243; BioLegend); PE anti-CD86 (clone IT2.2; Bio-
Legend); FITC anti-CD83 (clone HB15e; BioLegend); PE anti-CD1a
(clone HI149; eBioscience); anti-MHC class I (clone W6/32, purified
from hybridoma culture supernatants); anti–IL-10 (clone JES3-9D7;
BD); and anti–TGF-b (clone 9016; R&D Systems). DEX and VitD3
were from Sigma-Aldrich, and Zombie Green was from BioLegend. The
anti–Gal-1 (F8G7) mAb was generated, as described (33).
DC and NK cells
Monocytes and NK cells were isolated from blood from healthy volunteers
(provided either by the Blood Bank of the Province of Buenos Aires, La Plata,
Argentina, or by the Service of Transfusion Medicine, of the Hospital Churruca-
Visca, Buenos Aires, Argentina). Monocytes were isolated by immunomagnetic
selection of CD14+ cells using MACS (Miltenyi Biotec, Bergisch Gladbach,
Germany). NK cells were isolated using the RosetteSep NK cell enrichment
mixture (StemCell) and Ficoll-Paque Plus (Amersham Biosciences) centrifu-
gation. Purity of isolated cells was always .90%, as assessed by flow cy-
tometry (FC) as CD14+ or CD32CD56+ cells. Monocytes were cultured for 6 d
with GM-CSF and IL-4 to obtain immature DC (iDC). To obtain mDC, iDC
were cultured for 5 or 24 h with 0.1 mg/ml LPS (E. coli 0111:B4 strain; Sigma-
Aldrich). To obtain regDC, iDC were cultured for 5 or 24 h with 0.1mg/ml LPS
and 5 nMDEX (regDCDEX), 10 nM VitD3 (regDCVitD3), or 5 and 10 nMVitD3
(regDCDEX+VitD3). DC were cultured with NK cells at a 1:1 ratio for 18 h, in the
absence or in the presence of blocking/neutralizing mAb in RPMI 1640 (Life
Technologies) supplemented with 10% inactivated FBS (Life Technologies),
sodium pyruvate, glutamine, and gentamicin (Sigma-Aldrich). In some ex-
periments, NK cells were cultured for 24 h with 10 ng/ml IL-12, 1 ng/ml IL-15,
and 10 ng/ml IL-18 in the absence or in the presence of DEX. Cell cultures
were used for analysis of apoptosis, cytokine production, and cell surface ex-
pression of specific receptors. Studies have been approved by the institutional
review committee of the Institute of Biology and Experimental Medicine. To
obtain conditioned media, DC were washed and cultured for up to 24 h with
fresh medium, and cell culture supernatants were stored at 270˚C until used.
ELISA for cytokines
Secretion of IFN-g by human NK cells was analyzed by ELISA, as de-
scribed (34). Detection of IL-12 and IL-10 was performed using the
ELISA MAX Standard kits from BioLegend, and detection of IL-18
was performed using the anti-human IL-18 matched pair of mAb clone
125-2H and biotinylated clone 159-12B (R&D Systems) and HRP-labeled
streptavidin (BioLegend).
Flow cytometry
Expression of cell surface receptors on DC and NK cells was analyzed
by FC using fluorochrome-labeled mAbs, as previously described (35).
Expression of Helios and T-bet was analyzed by intracellular FC using
Cytofix/Cytoperm (BD). Cells were analyzed in a FACSCanto II flow
cytometer (BD). Results were expressed as geometric mean fluorescence
intensity or as percentage of positive cells. Data were analyzed using
FlowJo X software (Tree Star).
Viability and apoptosis
Apoptosis of NK cells was assessed using annexin V conjugated to FITC
(BD) or allophycocyanin (eBioscience), using the apoptosis detection kit
(BD) following manufacturer’s instructions. Viability of DC was assessed
using Zombie Green following manufacturer´s instructions.
Statistical analysis
Two-way ANOVA with Bonferroni´s correction was used for comparison
of expression of cell surface markers on DC and NK cells. One-way
ANOVA with Dunnett’s or Bonferroni’s post hoc test or paired t tests
were used for comparison between experimental groups, as indicated in the
legend for each figure. Data were analyzed using GraphPad Prism 6.0
software.
Results
regDC restrain NK cell–derived IFN-g production through
secretion of suboptimal amounts of IL-18
We first generated different regDC from iDC differentiated from
monocytes and matured with LPS in the presence of DEX, VitD3,
or DEX and VitD3, and performed their phenotypical and
functional characterization (Fig. 1). Although these regDC were
similar to mDC in terms of expression of CD1a (data not shown)
and MHC class II, they expressed lower amounts of the co-
stimulatory molecules CD83 and CD86 (Fig. 1A, 1B). Importantly,
all regDC, regardless of the stimulus used, exhibited a poor capacity
to produce IL-12 when compared with mDC (Fig. 1C). Moreover,
regDC generated with DEX or with DEX and VitD3, but not regDC
generated with VitD3 alone, secreted less IL-10 than mDC, but these
differences did not reach statistical significance (Fig. 1D). To in-
vestigate the effect of regDC on NK cells, we performed cocultures
of iDC, mDC, and different regDC with freshly isolated NK cells
and assessed the production of IFN-g as surrogate parameter in-
dicative of NK cell effector function (Fig. 2). As expected, mDC, but
not iDC, induced robust IFN-g secretion by NK cells. In contrast,
regDC generated with DEX, VitD3, or DEX and VitD3 elicited
secretion of very low amounts of this cytokine (Fig. 2A). As DEX-
induced regDC showed lower CD86 expression, elicited a more
robust effect on NK cell–derived IFN-g than other regDC, and dis-
played similar amounts of CCR7 than mDC (indicating that they can
migrate to secondary lymph nodes similar to mDC), subsequent
experiments were performed with DEX-induced regDC. Moreover,
because these previous experiments were performed with allogeneic
combinations of cells, we repeated the experiment with syngeneic
combinations (using NK cells that were cryopreserved at the time
that monocytes were isolated). As with allogeneic combinations of
cells, DEX-induced regDC failed to stimulate IFN-g secretion by
syngeneic NK cells (Fig. 2B), thus substantiating the results obtained
with allogeneic cell combinations.
To explore the mechanisms underlying regDC–NK cell cross-
talk, we performed new experiments using extensively washed
regDC (Fig. 2C), as well as mDC- and regDC-derived conditioned
media to evaluate their effect on IFN-g secretion by NK cells
(Fig. 2D). In both cases, we observed that NK cells secreted high
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amounts of IFN-g upon coculture with extensively washed mDC
(Fig. 2C) or upon culture with conditioned media from mDC
(Fig. 2D), but not when they were cocultured with extensively
washed regDC (Fig. 2C) or when they were exposed to condi-
tioned media from regDC (Fig. 2D). As regDC were generated
with DEX and glucocorticoids such as methylprednisolone exert
inhibitory effects on NK cells (36), we analyzed the direct effect
of DEX in our experimental setting (Fig. 2E). We observed that
DEX only partially inhibited IFN-g secretion by NK cells stim-
ulated with IL-12 and IL-18. These results suggest the occurrence
of additional mechanisms through which conditioned media from
regDC restrain IFN-g production by NK cells. Moreover, the
unresponsiveness of NK cells cultured with regDC was not due to
regDC-induced NK cell apoptosis (Fig. 2F) or to NK cell–induced
DC death (Fig. 2G). Remarkably, coculture of NK cells with either
mDC or regDC induced a significant increase in the percentages of
CD25+ NK cells (Fig. 2H, 2K) and CD69+ NK cells (Fig. 2I, 2K),
suggesting that regDC promote NK cell activation. However, only
mDC, but not regDC, induced a statistically significant upregu-
lation of CD56 in the CD56dim NK cell population (Fig. 2J, 2L),
indicating that regDC cannot induce a full activation program on
NK cells as mDC. Upregulation of CD69 and CD25 was not
observed when NK cells were cultured with conditioned media
from mDC or regDC (data not shown), suggesting that such NK
cell activation is driven by cell-to-cell contact.
FIGURE 1. Characterization of regulatory DC. iDC, mDC, and regDC
generated in the presence of DEX (regDCDEX), VitD3 (regDCVitD3), or
a combination of DEX and VitD3 (regDCDEX+VitD3) were used to assess
expression of CD1a (data not shown); MHC class II molecules (MHC-II),
CD83, CD86, and CCR7 by FC [(A); representative histograms for these
markers on regDCDEX are shown in (B)]; secretion of IL-12 (C); and se-
cretion of IL-10 (D). Concentration of cytokines in cell culture supernatants
was assessed by ELISA. Mean 6 SEM of DC from at least four different
donors is shown in (A), (C), and (D). *p , 0.05, **p , 0.01, ***p , 0.001.
Two-way ANOVAwith Bonferroni’s post hoc test (A) and one-way ANOVA
with Dunnett´s post hoc test (C and D) were used.
FIGURE 2. regDC restrain IFN-g production by NK cells through sol-
uble factors and cell surface receptors. Allogeneic iDC, mDC, or regDC
generated in the presence of DEX (regDCDEX), VitD3 (regDCVitD3), or
a combination of DEX and VitD3 (regDCDEX+VitD3) were cocultured with
NK cells for 18 h, and IFN-g was assessed in cell culture supernatants by
ELISA (A). Also, syngeneic (B) or extensively washed (C) iDC, mDC, or
regDC generated with DEX were cocultured with NK cells for 18 h, and
IFN-g was assessed in cell culture supernatants by ELISA. Additionally,
NK cells were cultured with conditioned media from iDC, mDC, or regDC
generated in the presence of DEX (D), or with IL-12 and IL-18 in the
absence or in the presence of DEX (E), and IFN-g was assessed in cell
culture supernatants by ELISA. NK cell apoptosis (annexin V+CD56+
cells) was also assessed by FC after culture without (“alone”) or with iDC,
mDC, or DEX-induced regDC (F). Viability of iDC, mDC, and regDC
generated in the presence or absence of DEX was assessed after coculture
with NK cells using Zombie Green. The percentage of dead (Zombie-
Greenhigh) DC was plotted (G). Expression of CD25 (H), CD69 (I), and
CD56 (J) was assessed by FC on NK cells after coculture with iDC, mDC,
or regDC generated in the presence of DEX. Representative zebra plots of
CD25 and CD69 expression in CD32CD56+ gated NK cells are shown (K).
Representative histograms of CD56 expression on CD32CD56dim cells are
shown (L). Thin line: NK cells cocultured with iDC; thick line: NK cells
cocultured with mDC; filled gray: NK cells cocultured with regDC. Mean 6
SEM of 8, 6, 3, 2, 6, 4, 4, or 7 combinations of DC and NK cells from
different donors is shown in (A), (B), (C), (F), (G), (H), (I), and (J), respec-
tively. Mean 6 SEM of NK cells from 6 and 3 different donors is shown in
(D) and (E), respectively. *p , 0.05, **p , 0.01, ***p , 0.001. One-way
ANOVA with Dunnett’s post hoc test was used.
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As regDC secreted lower amounts of IL-12 than mDC, we
supplemented regDC-derived conditioned media with this cytokine
to explore whether insufficient amounts of IL-12 account for the
inability of these conditioned media to trigger IFN-g secretion by
NK cells (Fig. 3A). However, addition of IL-12 could not provide
NK cell–stimulating activity in the presence of regDC-derived
conditioned media. Instead, supplementation of regDC-derived
conditioned media with IL-18 successfully stimulated IFN-g se-
cretion by NK cells, although this effect was not observed when
IL-18 was directly added to culture medium (Fig. 3B). Accord-
ingly, assessment of IL-18 in cell culture supernatants confirmed
that regDC secreted considerably lower amounts of IL-18 than
mDC (Fig. 3C). In addition, regDC expressed higher amounts of
IL-18Ra (Fig. 3D), but not IL-18Rb (Fig. 3E), than mDC, al-
though NK cells cultured with regDC displayed similar amounts
of both receptor subunits as compared with NK cells cocultured
with mDC (Fig. 3F, 3G). Therefore, regDC actively curb IFN-g
secretion by NK cells through mechanisms mediated, at least in
part, by secretion of suboptimal concentrations of IL-18.
IL-10, NK cell inhibitory receptors, and NKp46 mediate
silencing of NK cell activity by regDC
To further investigate the mechanisms underlying the suppressive
effect of regDC on NK cells and given that IL-10, TGF-b, and Gal-
1 can be secreted by regDC and display T cell inhibitory activity
(19, 20, 26), we cultured NK cells with regDC-derived condi-
tioned media in the absence or in the presence of neutralizing
mAbs against these soluble mediators. Neutralization of Gal-1,
TGF-b, or IL-10 in mDC- or regDC-derived conditioned media
did not alter NK cell secretion of IFN-g induced by these DC
populations (Fig. 4A and data not shown). However, neutralization
of TGF-b or IL-10 during mDC–NK cell cocultures led to aug-
mented secretion of IFN-g by NK cells, whereas neutralization of
IL-10 during regDC–NK cell cocultures rescued the ability of regDC
to trigger IFN-g secretion by NK cells (Fig. 4B). Of note, we ob-
served a similar trend toward enhanced IFN-g production following
TGF-b blockade, although these data did not reach statistical sig-
nificance. These results suggest that regDC inhibits IFN-g secretion
by NK cells through IL-10–mediated mechanisms involving direct
cell-to-cell contact.
As extensively washed regDC restrained IFN-g production by
NK cells, we then studied whether NK cell receptors contribute to
such effect by performing coculture experiments in the absence or
in the presence of blocking mAb against different cell surface
receptors or cognate ligands (Fig. 5A–C). Surprisingly, we de-
tected substantial amounts of IFN-g in cocultures of NK cells and
regDC upon blockade of the activating receptor NKp46, but not
upon blockade of other activating receptors, such as NKG2D,
NKp30, or NKp44 (Fig. 5A). Such inhibitory role of NKp46 was
not verified when NK cells were cocultured with mDC (Fig. 5A).
The unexpected behavior of NKp46 in our experimental setting
was detected in both allogeneic (Fig. 5A) and syngeneic (Fig. 5B)
combinations of regDC and NK cells, suggesting a previously
unrecognized function for NKp46 during interactions between NK
cells and regDC. In addition, blockade of the interaction between
MHC class I molecules on regDC and NK cell receptors using the
W6/32 mAb induced increased IFN-g secretion (Fig. 5C), sug-
gesting that modulation of NK cell activity by regDC involves
engagement of the NK cell inhibitory receptors by MHC class I
molecules. Of note, iDC, mDC, and regDC generated by DEX
expressed similar amounts of NKp46 ligands (NKp46L), exclud-
ing the possibility of a differential engagement of NKp46 by mDC
versus regDC (Fig. 5D, 5E).
Previously, a loss-of-functionmutation in the Ncr1 gene (encoding
NKp46) was associated with silencing of the Helios transcription
factor in NK cells (37). In contrast, T-bet has been shown to be a
critical transcription factor involved in IFN-g production by NK
cells (38). As regDC suppressed IFN-g secretion by NK cells
through a mechanism involving NKp46, we explored whether
cocultures with iDC, mDC, or regDC modulated expression of
these transcription factors in NK cells (Fig. 6). We observed that
the proportion of NK cells expressing Helios was similar fol-
FIGURE 3. Suboptimal secretion of IL-18 by regDC contributes to re-
strain IFN-g production by NK cells. NK cells were cultured with con-
ditioned media from mDC (gray bars) or regDC generated in the presence
of DEX (black bars), or with culture medium (white bars) supplemented
with IL-12 (A) or IL-18 (B), and IFN-g secretion was assessed by ELISA.
As positive controls, NK cells were cultured with conditioned media from
regDC or with culture medium supplemented with IL-12, IL-15, and IL-
18. The concentrations of IL-18 were assessed in conditioned media from
mDC and regDC by ELISA (C). mDC or regDC generated in the presence
of DEX (D and E) and NK cells (F and G) were used to assess the ex-
pression of IL-18Ra (D and F) and IL-18Rb (E and G) chains by FC.
Results were expressed as the ratio of the mean fluorescence intensity
obtained with mDC or regDC compared with the mean fluorescence in-
tensity obtained with iDC. Mean 6 SEM of NK cells from at least 6 and 3
different donors is shown in (A) and (B), respectively. Individual values
from 14 different donors are shown in (C), whereas individual values from
at least 4 different donors are shown in (D)–(G). One-way ANOVA with
Bonferroni’s post hoc test was used in (A) and (B), whereas *p, 0.05, **p,
0.01. A paired t test was used to compare the data shown in (C)–(G).
FIGURE 4. IL-10 curbs IFN-g production during coculture of NK cells
with mDC or regDC. NK cells were cultured for 18 h with conditioned
media from iDC, mDC, or regDC generated in the presence of DEX (A) or
with iDC, mDC, or regDC generated in the presence of DEX (B) in the
absence or presence of neutralizing mAb against TGF-b or IL-10. The
concentrations of IFN-g were assessed in cell culture supernatants by
ELISA. Mean 6 SEM of NK cells from at least two different donors is
shown in (A), whereas mean 6 SEM of at least four combinations of DC
and NK cells from different donors is shown in (B). *p, 0.05, **p, 0.01,
***p, 0.001. One-way ANOVAwith Bonferroni’s post hoc test was used.
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lowing coculture with either mDC or regDC, and that these per-
centages were higher than the percentages of NK cells expressing
Helios following coculture with iDC (Fig. 6A, 6C). However, the
increased percentage of NK cells expressing Helios reached sta-
tistical significance only after coculture of NK cells with mDC,
but not with iDCs. Because a similar percentage of NK cells that
express Helios after coculture with mDC or with regDC was de-
tected, it is likely that differences in Helios expression do not
explain the different response of NK cells to mDC versus regDC.
Conversely, we observed a trend toward an increased percentage
of NK cells expressing T-bet upon coculture with mDC that was
not observed when NK cells were exposed to regDC, as compared
with iDC–NK cell cocultures (Fig. 6B, 6D).
Overall, our results indicate that regDC promote activation of
NK cells toward an alternative phenotype characterized by low
IFN-g secretion via mechanisms involving secretion of suboptimal
amounts of IL-18, synthesis of IL-10, and engagement of NKp46
and MHC class I–specific receptors. Our results contribute to
unravel the mechanisms that control interactions between human
regDC and NK cells and disclose a previously unanticipated reg-
ulatory function for NKp46 in the control of NK cell activation.
Discussion
Following the seminal work describing the functional consequences of
the interaction between DC and NK cells (39), many soluble medi-
ators and cell surface receptors that participate in this cross-talk have
been characterized (1, 2, 6, 7, 16, 40–50). It has been demonstrated
that NK cells and DC establish a cross-talk that promotes their re-
ciprocal activation, strengthening the secretion of proinflammatory
cytokines such as IL-12, IL-15, and IFN-g, endowing DC with the
ability to skew the adaptive immune response toward a Th1- and
CTL-mediated profile (1, 2, 7, 16, 51, 52). Also, iDC that remain
refractory to maturation can be lysed by NK cells, a phenomenon that
seems to function as an editing process through which NK cells check
proper maturation of DC in response to pathogens and avoid the
delivery of anergy-inducing signals to T cells (7). Expression of
CD94/NKG2A has been involved in the acquisition of DC resistance
to NK cell–mediated lysis (53).
Regulatory DC play key roles as they are expanded by tumors to
promote immune tolerance (13, 19), and ex vivo–generated regDC
have been proposed as useful tools for the treatment of patients
with autoimmune diseases (21) and for inducing graft-specific
tolerance in transplanted patients (22). As they can be generated
in vitro by DEX, regDC may also become expanded in patients
chronically treated with glucocorticoids (11). Importantly, the
effect of the outcome of the interaction between regDC and NK
cells has not yet been explored. In this work, we found that regDC
generated by DEX, VitD3, or the combination of both expressed
less costimulatory molecules and were poor producers of IL-12
when compared with mDC. These regDC, as opposed to mDC,
were unable to trigger IFN-g secretion by NK cells. Because regDC
generated by DEX displayed less CD86, showed more robust in-
hibition of NK cell–derived IFN-g secretion than other regDC, and
displayed similar amounts of CCR7 than mDC (indicating their
similar capacity to migrate to secondary lymph nodes), most ex-
periments in this study were performed with regDC generated by
FIGURE 5. NKp46 displays inhibitory activity during the cross-talk
between NK cells and regDC. NK cells were cocultured with allogeneic
iDC, mDC, or regDC generated in the presence of DEX in the absence or
in the presence of blocking mAb against NKG2D, NKp30, NKp44, or
NKp46 (A), and IFN-g was assessed in cell culture supernatants by ELISA.
NK cells were also cocultured with syngeneic regDC generated in the
presence of DEX in the absence or presence of anti-NKp46 blocking mAb
(B), or NK cells were cocultured with allogeneic iDC, mDC, or regDC
generated in the presence of DEX in the absence or presence of blocking
mAb against MHC class I molecules (C), and IFN-g was assessed in cell
culture supernatants by ELISA. Expression of NKp46L was assessed on
iDC, mDC, or regDC produced with DEX by FC, as described inMaterials
and Methods (D). Representative histograms are shown (E). Mean 6 SEM
of NK cells from 4 (A), 6 (B), and 3 (C) combinations of DC and NK cells
from different donors is shown. Mean 6 SEM of three DC from different
donors is shown in (D). *p , 0.05, **p , 0.01, ***p , 0.001. One-way
ANOVA with Bonferroni’s post hoc test was used.
A
C
D
B
FIGURE 6. Expression of Helios and T-bet transcription factors in NK
cells upon interaction with different DC. NK cells were cocultured with
allogeneic iDC, mDC, or regDC generated in the presence of DEX, and the
expression of Helios (A) and T-bet (B) was assessed by FC in CD32CD56+
gated cells. Mean 6 SEM from four independent experiments performed
with NK cells from different donors is shown. Representative zebra plots
for Helios (C) and T-bet (D) in CD56+ NK cells are also shown. One-way
ANOVA with Dunnett’s post hoc test was used.
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DEX treatment. Using DEX-induced regDC, we demonstrated that
their inability to trigger IFN-g secretion by NK cells was mediated
by soluble factors and cell surface receptors. Although IL-12 is one
of the major cytokines produced by mDC and involved in NK cell
stimulation (1, 34, 54, 55), we found that the capacity of regDC
to suppress IFN-g production by NK was not due to insufficient
amounts of IL-12 in the culture media. However, we found that
secretion of insufficient amounts of IL-18 by regDC actively con-
tributes to their inhibitory activity on NK cells. Remarkably,
priming of NK cells by IL-18 has been shown to be critical for
helper NK cell function such as production of iDC-attracting che-
mokines CCL3 and CCL4, which attract iDC in a CCR5-dependent
manner and induce production of CXCL9, CXCL10, and CCL5 by
DC, promoting subsequent recruitment of type 1 effector CD8+
T cells (56). In addition, activation of IL-18–primed helper NK cells
by cytokines such as IFN-a, IL-15, IL-12, and IL-2 stimulates DC-
mediated production of CCL19 and CCR7-mediated recruitment of
naive CD8+ T cells into lymph nodes (57). Therefore, it has been
suggested that the therapeutic use of combinatorial adjuvants con-
taining IL-18 may facilitate the induction of antitumor immune
responses. Accordingly, our observation that regDC secrete sub-
optimal doses of IL-18 that in turn prevents NK cell–mediated
IFN-g secretion may constitute one of the mechanisms employed
by tumor-expanded regDC to facilitate tumor immune escape. Of
note, regDC expressed higher amounts of IL-18Ra than mDC,
which might indicate their ability to recapture secreted IL-18,
influencing the bioavailability of IL-18 for NK cells.
Notably, exposure of NK cells to regDC did not affect the vi-
ability of any of these cells. Conversely, regDC induced activation
of NK cells toward an alternative phenotype, as judged by the
upregulation of CD25 and CD69 without inducing the upregulation
of CD56 in the CD56dim NK cell subpopulation (as did mDC).
Although upregulation of CD69 did not reach statistical signifi-
cance, it should be kept in mind that NK cells were analyzed after
an overnight culture with DC, whereas full upregulation of CD69
usually requires 48–72 h of stimulation. In addition, we demon-
strated that IL-10 and TGF-b restrain IFN-g secretion by NK cells
during their cross-talk with mDC, but that only IL-10 contributes
to prevent IFN-g secretion by NK cells upon interacting with
regDC. We speculate that IL-10 most likely acts through an
autocrine/paracrine effect on regDC, as blockade of IL-10 only
restored IFN-g secretion when NK cells were cocultured with
regDC, but not when NK cells were cultured with conditioned
media derived from regDC.
Moreover, engagement of NK cell inhibitory receptors that
recognize MHC class I molecules also contributes to thwart IFN-g
production by NK cells upon interaction with regDC. We can
speculate that inhibitory KIRs (KIR2/3DLs), CD94/NKG2A, or
some members of the Ig-like transcript family such as ILT2-6
could be involved in this response, as they recognize MHC class
I molecules (58–60). Unexpectedly, blockade of the activating
receptor NKp46 restored IFN-g secretion by NK cells upon con-
tacting regDC, which unveils a previously unrecognized regula-
tory function for this receptor during regDC–NK cell cross talk.
Such effect was not due to a differential engagement of NKp46
on NK cells upon contact with mDC versus regDC, as expression
of NKp46L was identical in both cell types. Previously, a minor
stimulatory role for NKp46 during the cross-talk between NK
cells and DC matured in the presence of IL-1, IL-6, TNF-a, and
PGE2 (3) or TNF (5) was observed. Others found that NKp46 and
NKG2D play a role in the cross-talk between NK cells and virus-
infected, but not uninfected, human DC (61, 62). The discrep-
ancies with our results could be due to the fact that we used resting
NK cells cultured for 18 h with DC, whereas, in some of these
studies, activated NK cells cultured with IL-2 (3, 5) or NK cells
exposed to virus-infected DC (61, 62) were used. Moreover, the
identification of mutant mice with a loss-of-function mutation in
the gene encoding NKp46 (Ncr1), which showed increased re-
sistance to viral infections associated with hyperresponsive NK
cells, enabled the assignment of a previously unrecognized in-
hibitory role of NKp46 in setting the threshold of NK cell re-
sponsiveness and a negative role for the Helios transcription factor
in this process (37). However, in our experimental setting, we did
not observe differences in the percentage of NK cells that express
Helios after coculture with mDC or regDC, making unlikely that
the silencing role of NKp46 on IFN-g production in human NK
cells during their cross-talk with regDC may involve changes in
the expression of Helios. However, we found a tendency of regDC,
but not mDC, to trigger lower percentages of NK cells expressing
T-bet, a transcription factor required for IFN-g production (38),
suggesting that a T-bet–regulated pathway may underlie the regDC–
NK cell inhibitory crosstalk.
Overall, our results identify a novel regulatory circuit activated
during the cross-talk between NK cells and regDC. Although the
interaction between mDC and NK cells is pivotal for the promotion
of Th1- and CTL-mediated immune responses (1–3, 16), regDC
are relevant for the homeostasis of the immune response (20), they
become expanded during tumor growth and contribute to tumor-
immune escape (13, 17–19), and constitute promising tools for
immunotherapy to harness excessive proinflammatory immune
responses during autoimmune diseases (21) and transplant rejec-
tion (22). Our results indicate that such functions may partially
involve the ability of regDC to activate NK cells toward an al-
ternative phenotype characterized by upregulated expression of
CD25 and CD69, but not of CD56, and presumably the induction
of lower percentages of T-bet+ NK cells, leading to a NK cell
phenotype with impaired ability to produce IFN-g. The mecha-
nisms underlying this effect entail the production of suboptimal
secretion of IL-18 by regDC, as well as the activation of a regu-
latory pathway involving IL-10, MHC class I–specific inhibitory
receptors, and engagement of NKp46. Accordingly, NKp46 dis-
plays a regulatory function during the interplay between regDC
and NK cells that, integrated with other immune inhibitory path-
ways, may contribute to the resolution of inflammatory responses
and evasion of antitumor responses, thus highlighting the rele-
vance of NK cell plasticity at the crossroads of immune tolerance
and activation.
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